June 7, 2017September 1, 2022

New CDC Infographic Shows 1 in 7 American Adults Now Have Chronic Kidney Disease

News

The number of Americans living with chronic kidney disease (CKD) might be higher than previously estimated, with new data from the Centers for Disease Control and Prevention (CDC) now pointing ... Read more

June 5, 2017

Mayo Clinic and Baxter to Partner on Therapies for Kidney Disease and Other Conditions

News

The Mayo Clinic and the dialysis equipment specialist Baxter International will work together on treatments for a range of conditions, starting with kidney disease. Fourteen percent of Americans have chronic kidney disease, according ... Read more

June 2, 2017November 16, 2017

Most U.S. and European Doctors Want Therapies to Keep Diabetic Kidney Patients from Having to Go on Dialysis

News

More than two-thirds of U.S. and European physicians believe there is a need for therapies to prevent kidney disease from diabetes becoming so severe that patients must go on dialysis ... Read more

May 31, 2017May 31, 2017

Kidney Care Partners Applauds U.S. Bipartisan Legislation for Americans with CKD or End-stage Renal Disease

News

Kidney Care Partners (KCP) welcomed the introduction of a bipartisan bill that improves and expands access to care for the more than 636,000 Americans living with chronic kidney disease (CKD) or end-stage ... Read more

May 26, 2017May 26, 2017

Resverlogix Welcomes Study Highlighting Apabetalone for CKD-Related Cardiovascular Disease

News

A new article highlights the mechanism of action of apabetalone to treat cardiovascular disease in patients with chronic kidney disease (CKD), reports Canadian pharmaceutical company Resverlogix. Cardiovascular disease is the main cause of ... Read more

May 24, 2017May 24, 2017

Avacopan Named Orphan Drug in Europe for Potential to Treat C3 Glomerulopathy

News

Avacopan (CCX168) has been designated an orphan medicinal product by the European Medicines Agency (EMA) for the treatment of a severe kidney disease called C3 glomerulopathy (C3G). ChemoCentryx said that a multi-center clinical ... Read more

May 22, 2017May 22, 2017

Obesity Is an Important CKD Risk Factor in Elderly People, Study Finds

News

Higher amounts of body fat were linked to an increased risk of chronic kidney disease (CKD) in elderly people, a study published in the Clinical Journal of the American Society ... Read more

May 19, 2017

FDA Approves Design of Phase 2a Trial of Apabetalone for Kidney Disease Patients on Dialysis

News

U.S. regulators have approved the design of a Phase 2a clinical trial of Resverlogix’s apabetalone for treating chronic kidney disease (CKD) patients who are on dialysis. The approval came from the U.S. Food and ... Read more

May 17, 2017May 17, 2017

Vifor Pharma to Provide Akebia’s Anemia Therapy Vadadustat to Group of US Dialysis Clinics

News

Vifor Pharma Group has obtained exclusive rights to sell Akebia Therapeutics‘ kidney-disease-related anti-anemia treatment vadadustat (AKB-6548) to Fresenius Medical Care dialysis clinics in the United States. The licensing agreement will kick in when ... Read more

May 15, 2017

Kidney Care Provider DaVita Is Taking Part in Mental Health Awareness Effort

News

The kidney care provider DaVita is joining this year’s May is Mental Health Month campaign to highlight the need for doctors to address patients’ mental health when they treat challenging physical conditions such as ... Read more

May 12, 2017May 12, 2017

Vitamin D Supplement’s Effects on Cardiovascular Mortality of CKD Patients Requires Further Research

News

Vitamin D supplements may reduce mortality in chronic kidney disease (CKD) patients who are substantially deficient in vitamin D — including those on dialysis, but clinical trials are required to ... Read more

May 10, 2017

Lupus-induced Kidney Damage Explained by Expert to Mark Lupus Awareness Month

News

Lupus Awareness Month in May was established to increase public awareness and understanding of this autoimmune disease. Many people still know very little about lupus and its detrimental impact on the ... Read more

May 8, 2017

Targeting Energy-creating Pathway Could Slow Diabetic Kidney Disease Progression, Study Reports

News

Targeting the biological pathway that converts cells’ glucose to energy may be a way to slow down the progression of diabetic kidney disease, according a study at the Joslin Diabetes Center in ... Read more

May 5, 2017

First Creatinine Values at Hospital Admission Can Be Used to Assess Acute Kidney Injury

News

Researchers from Canada showed that using serum creatinine (SCr) values obtained at the time of hospital admission is a reliable method for assessment of acute kidney injury (AKI). In the ... Read more

May 3, 2017May 3, 2017

Xenetic’s Lead Drug Candidate ErepoXen Shows Encouraging Results In CKD Clinical Study

News

Results from a clinical trial of ErepoXen — a therapy developed by Xenetic Biosciences to treat anemia in chronic kidney disease (CKD) patients, show promise, company officials said in a review of their proprietary ... Read more

April 28, 2017April 28, 2017

Chronic Kidney Disease Patients More Likely to Have Gout than Those Without CKD, Study Finds

News

About 10 percent of Americans with chronic kidney disease (CKD) also have gout, concludes a large-scale study based on the National Health and Nutrition Examination Survey (NHANES). The study also ... Read more

April 25, 2017April 25, 2017

Cricket Health Says its Modality Choice Program Helps CKD Patients Choose Treatment Plan

News

Education, combined with an integrated patient and provider online community, increases the likelihood that people with late-stage chronic kidney disease (CKD) opt for at-home dialysis, pre-emptive transplant or palliative care instead ... Read more

April 21, 2017

Veltassa Normalizes Blood Potassium in Kidney Disease with or Without Food, Trial Shows

News

Veltassa (patiromer) is an effective treatment against hyperkalemia, or excessive levels of potassium in the blood, whether chronic kidney disease (CKD) patients take it with or without food, a clinical trial ... Read more

April 19, 2017April 19, 2017

New Prognostic Test May Improve Clinical Trial Study Design for Types 1 and 2 Diabetes Patients

News

Researchers at Boston’s Joslin Diabetes Center have developed a prognostic tool that predicts the risk of end-stage renal disease (ESRD) in patients with type 1 or type 2 diabetes. “Overall efficiency and ... Read more

April 17, 2017April 17, 2017

Connie Rhee Receives ATA Grant to Study Thyroid Dysfunction, Depression in CKD Patients

News

The American Thyroid Association (ATA) has awarded Connie Rhee, MD, a grant to study how thyroid dysfunctions increase the risk of depression and reduced health-related quality of life in patients ... Read more